Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

7

Number of overlapping holdings

11.7%

% of XLV's 60 holdings also in XPH

17.5%

% of XPH's 40 holdings also in XLV

Overlap by Weight
Sector Drift (XLV minus XPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XLV
Weight
in XPH
Overlap
ELI LILLY & CO 13.4% 4.3% 4.3%
JOHNSON & JOHNSON 7.7% 4.1% 4.1%
MERCK & CO. INC. 4.0% 3.6% 3.6%
PFIZER INC 2.5% 3.7% 2.5%
BRISTOL-MYERS SQUIBB CO 2.0% 3.5% 2.0%

Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to XPH
ELI LILLY & CO 9.1%
UNITEDHEALTH GROUP INC 8.5%
ABBVIE INC 6.2%
ABBOTT LABORATORIES 4.6%
JOHNSON & JOHNSON 3.6%
INTUITIVE SURGICAL INC 3.5%
THERMO FISHER SCIENTIFIC INC 3.3%
AMGEN INC 3.0%
BOSTON SCIENTIFIC CORP 2.8%
GILEAD SCIENCES INC 2.6%
XLV Underweight Relative to XPH
CORCEPT THERAPEUTICS INC -4.8%
TARSUS PHARMACEUTICALS, INC. -4.2%
ROYALTY PHARMA PLC CLASS A -4.2%
PERRIGO CO -3.9%
PRESTIGE BRANDS HOLDINGS INC -3.9%
AXSOME THERAPEUTICS, INC. -3.7%
ELANCO ANIMAL HEALTH, INC. -3.5%
VIATRIS, INC. -3.3%
JAZZ PHARMACEUTICALS PLC -3.3%
PACIRA PHARMACEUTICALS INC -3.2%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY